Clonazepam

ADVERTISEMENT

Identification

Molecular formula
C15H10ClN3O2
CAS Number
1622-61-3
IUPAC Name
7-chloro-N-cyclopropyl-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-imine
Molecular Weight
315.72g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
2.0040g/cm3
Synonyms
3H-1, 4-BENZODIAZEPINE, 7-CHLORO-2-(CYCLOPROPYLAMINO)-5-PHENYL-, 4-OXIDE
Interesting facts

Interesting Facts About 7-Chloro-N-cyclopropyl-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-imine

This compound, part of the benzodiazepine family, features a complex structure that provides it with intriguing properties and potential applications. Here are some interesting aspects of this subclass of benzodiazepines:

  • Structure and Activity: The incorporation of a cyclopropyl group and chloro substitution significantly influences the pharmacological activity of the compound. These structural modifications can enhance binding affinity to specific receptors in the central nervous system.
  • Therapeutic Potential: Compounds of this class are often investigated for their anxiolytic, sedative, and anticonvulsant properties. The unique structure may offer new therapeutic avenues, particularly in managing anxiety disorders and epilepsy.
  • Research Interests: Due to their varied mechanisms of action, benzodiazepines like this compound continue to be a focus in medicinal chemistry. Scientists are exploring ways to develop derivatives that could lead to fewer side effects compared to traditional benzodiazepines.
  • Safety Concerns: While they can be highly effective, some benzodiazepines have been associated with dependency issues. This underscores the importance of ongoing research to create compounds that balance efficacy with safety.

As we delve deeper into the world of medicinal chemistry, the study of 7-chloro-N-cyclopropyl-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-imine and similar compounds is crucial in the quest for more effective and safer therapeutic agents. Understanding their mechanisms enables chemists to innovate new drugs that could transform patient care.

ADVERTISEMENT